# Ciprofloxacin Plus Metronidazole Vs Cefixime Plus Metronidazole Therapy for the Treatment of Liver Abscess

> **NCT03969758** · PHASE3 · UNKNOWN · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 140 (estimated)

## Conditions studied

- Liver Abscess

## Interventions

- **DRUG:** Ciprofloxacin
- **DRUG:** Cefixime

## Key facts

- **NCT ID:** NCT03969758
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2019-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03969758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03969758, "Ciprofloxacin Plus Metronidazole Vs Cefixime Plus Metronidazole Therapy for the Treatment of Liver Abscess". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03969758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*